MedPath

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

109

Active:5
Completed:39

Trial Phases

5 Phases

Phase 1:7
Phase 2:9
Phase 3:13
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (64 trials with phase data)• Click on a phase to view related trials

Not Applicable
26 (40.6%)
Phase 3
13 (20.3%)
Phase 2
9 (14.1%)
Phase 4
9 (14.1%)
Phase 1
7 (10.9%)

Clinical and Ecological Impact of a Primary Care Antimicrobial Stewardship Program Based on Telematic Educational Interviews (TELÉMACO Trial)

Not Applicable
Recruiting
Conditions
Community Acquired Infections
First Posted Date
2024-11-26
Last Posted Date
2024-11-26
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
30
Registration Number
NCT06706583
Locations
🇪🇸

Hospital Universitario Virgen del Rocío, Sevilla, Spain

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients

Not Applicable
Completed
Conditions
Non-alcoholic Fatty Liver Disease (NAFLD)
First Posted Date
2024-11-14
Last Posted Date
2024-11-14
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
536
Registration Number
NCT06688149
Locations
🇩🇪

University Hospital Düsseldorf, Düsseldorf, Germany

🇩🇪

University Medical Center Mainz, Mainz, Germany

🇬🇷

Harokopio University of Athens, Athens, Greece

and more 1 locations

TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase 2
Not yet recruiting
Conditions
Myelodysplastic Syndromes
Myeloid Leukemia, Acute
Interventions
Drug: Total bone marrow and lymphoid irradiation/cyclophosphamide/etoposide
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
58
Registration Number
NCT06598969
Locations
🇪🇸

Hospital Universitario Virgen del Rocío, Sevilla, Spain

TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.

Phase 2
Not yet recruiting
Conditions
Myelodysplastic Syndromes
Acute Myeloid Leukemia
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
34
Registration Number
NCT06602323

Utility of Preanestes@s2.0, a Web Based Application for Preoperative Assessment.

Not Applicable
Not yet recruiting
Conditions
Mobile Application
Preoperative Period
Internet-based Intervention
Surgical Procedures, Elective
Assessment Evaluation
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
2254
Registration Number
NCT06602310
Locations
🇪🇸

Hospital Universitario Virgen Macarena, Seville, Spain

🇪🇸

Hospital Universitario Virgen Del Rocío, Seville, Spain

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 22
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath